The use of methylisothiazolinone (known as MIT) in cosmetics has been condemned by Dr David Orton of the British Association of Dermatologists (BAD).
MIT singled out for causing allergies
Dr David Orton condemned the rise in skin allergies from some beauty and personal care product ingredients
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You may also like
Trending Articles
You may also like
Regulatory
Neutrogena owner agrees $4.7 million settlement over Skin360 biometric data privacy claims
Johnson & Johnson Consumer, which is now known as Kenvue, has agreed to a settlement in a class action lawsuit, in which it was alleged that the skin care brand’s facial scanning technology collected and stored data without users’ consent
Regulatory
Anton Paar expands litesizer portfolio with cost-effective DLS 301 for routine analysis
Anton Paar has announced the launch of the Litesizer DLS 301, the latest addition to its established Litesizer family. Designed as a budget-friendly solution for routine analysis, the new instrument provides reliable performance for laboratories working with simpler samples and straightforward quality control workflows
Regulatory
Italy launches probe into Procter & Gamble over ‘misleading’ advertising
Italy’s competition authority, Autorità Garante della Concorrenza e del Mercato (AGCM), has launched an investigation into the company’s adverts for a Braun hair removal device which it says may have misled consumers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
Women and Equalities Committee urges UK Government for urgent ‘de facto ban’ on BBLs
The committee has released its 11th report on cosmetic procedures, calling for ‘high harm’ procedures, such as Brazilian Butt Lifts (BBLs) and liquid breast augmentation, to be banned immediately, while highlighting the dangers of cosmetic tourism
Regulatory
Olalla Consulting broadens european footprint to support compliant, science-led brand innovation
Olalla Consulting LTD announces its continued expansion across the UK and EU, strengthening its position as a leading technical partner for beauty, skincare, and healthcare brands seeking regulatory clarity and scientifically robust product development